MGC Pharmaceuticals / Argent BioPharma MGC Pharmaceuticals has become the latest UK-listed cannabis company to opt for a rebrand
Akanda Akanda has seen its share price slip by around 10% this week after it announced plans to sell
Canadian cannabis giant Aurora yesterday announced plans to enact a 1:10 stock consolidation in order to avoid delisting from the
Chill Brands Chill Brands has seen its stock price drop by more than 30% this week following news that
Ananda Developments Aquis-listed pharmaceutical cannabis company Ananda Developments welcomed two new scientific advisors ‘to assist the company in developing
Akanda Akanda has seen its stock rise by around 7% this week as it rode the wave of positive
Cellular Goods (Cel AI) Cellular Goods has this morning announced another major pivot in its strategy, just days after
European cannabis stocks in 2023 2023 has been perhaps the hardest financial year to date for the emerging European cannabis
Celadon Pharmaceuticals Celadon Pharmaceuticals this week passed a ‘significant milestone’ as it completed its first ever supply delivery to
Chill Brands Chill Brands published a ‘trading update’ to investors this morning, revealing growth in a number of key
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.